Zurcher Kantonalbank (Zurich Cantonalbank) Legend Biotech Corp Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Legend Biotech Corp stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 40,906 shares of LEGN stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,906
Previous 40,913
0.02%
Holding current value
$1.16 Million
Previous $1.33 Million
4.21%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$196 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$190 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$169 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$162 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$106 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $4.74B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...